| 
|  | Vatalanib DihydrochlorideDescription of:Vatalanib DihydrochlorideVatalanib is a potent, selective, orally active inhibitor of the VEGFR tyrosine kinases VEGFR-1 (Flt-1...
 更多>> |  | 
| 
|  | CP-673451Description of:CP-673451In a sponge angiogenesis model, CP-673451 inhibited 70% of PDGF-BB-stimulated angiogenesis at a dose of 3 mg/kg ...
 更多>> |  | 
| 
|  | KRN633Description of:KRN633KRN633 inhibits PDGFR-α and c-Kit at higher concentrations only (IC50 = 0.97 µM and 4.33 µM, respective...
 更多>> |  | 
| 
|  | Cabozantinib|卡博替尼Description of:CabozantinibCabozantinib was granted orphan-drug status by the FDA in January 2011.It is currently in a number of clinical tria...
 更多>> |  | 
| 
|  | Pazopanib(帕唑帕尼)Theoretical analysis:Pazopanib(GW-786034)M.Wt: 473.98
 Formula: C21H23N7O2S.HCL
 Solubility: Soluble in DMSO at 10 mmol/L
 P...
 更多>> |  |